Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
A comparison of the efficacy of APD421 and placebo when combined with a standard anti-emetic
in the prevention of PONV in patients at high risk of Post-operative Nausea and Vomiting
(PONV).